Topical Delgocitinib in Patients With Chronic Hand Eczema Topical Delgocitinib in Patients With Chronic Hand Eczema

Review the results of a Phase IIa study on the use of delgocitinib ointment, a novel pan-Janus kinase inhibitor, in patients with chronic hand eczema.The British Journal of Dermatology

Source: Medscape Allergy Headlines - June 19, 2020 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news